Product Information

METHIMAZOLE 5 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.0706 per EA under NDC 62135020590. Its NADAC has been published 250 times since Feb 9, 2022.

FDA first approved this application on Mar 27, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHIMAZOLE 5 MG TABLET

Methimazole
$0.0706per EA

Strength

5 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135020590

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

METHIMAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA040411

FDA Approved

3/27/2001

TE Code

AB

On Market Since

3/27/2001

Pharmacological Classes

Thyroid Hormone Synthesis Inhibitor
Thyroid Hormone Synthesis Inhibitors

Price Statistics

The NADAC for METHIMAZOLE 5 MG TABLET has been published 250 times since Feb 9, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0706 per EA
All-time high$0.1140 (Sep 13, 2023)
All-time low$0.0602 (May 18, 2022)
52-week high$0.0788
52-week low$0.0694
Median price$0.0746
Average price$0.0776
Largest weekly change+27.3% (Aug 23, 2023)
Weeks tracked250
Tracking sinceFeb 9, 2022

Price History

1W

+1.7%

1M

+0.5%

3M

-0.2%

6M

-2.0%

1Y

-10.5%

3Y

-25.8%

5Y

N/A

All

-0.4%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METHIMAZOLE 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METHIMAZOLE 5 MG TABLET, manufactured by Chartwell RX LLC, is $0.0706 per EA (NDC 62135020590), effective Nov 18, 2026.

How has the price of METHIMAZOLE 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for METHIMAZOLE 5 MG TABLET has held within roughly two percent of its current level. It has been tracked across 250 weekly CMS publications since Feb 9, 2022.

What are the highest and lowest recorded NADAC prices for METHIMAZOLE 5 MG TABLET?

Since Feb 9, 2022, the NADAC for METHIMAZOLE 5 MG TABLET has ranged from a low of $0.0602 (May 18, 2022) to a high of $0.1140 (Sep 13, 2023), with a median of $0.0746 per EA.

Are there cheaper alternatives to METHIMAZOLE 5 MG TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHIMAZOLE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures METHIMAZOLE 5 MG TABLET?

METHIMAZOLE 5 MG TABLET (NDC 62135020590) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.